Tacjana Pressler

<i>Pseudomonas aeruginosa</i> biofilms in the respiratory tract of cystic fibrosis patients

Thomas Bjarnsholt, Peter Østrup Jensen, Mark J. Fiandaca et al. · Pediatric Pulmonology · 2009 · 790 citations

Life Sciences, Infectious Diseases, Microbiology +17

Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis

Peter Garred, Tacjana Pressler, Hans O. Madsen et al. · Journal of Clinical Investigation · 1999 · 438 citations · Full text

Life Sciences, Genetics, Microbiology +17

Rapid necrotic killing of polymorphonuclear leukocytes is caused by quorum-sensing-controlled production of rhamnolipid by Pseudomonas aeruginosa

Peter Østrup Jensen, Thomas Bjarnsholt, Richard K. Phipps et al. · Microbiology · 2007 · 405 citations

Life Sciences, Immunology, Microbiology +17

Efficacy and safety of lumacaftor and ivacaftor in patients aged 6–11 years with cystic fibrosis homozygous for F508del-CFTR : a randomised, placebo-controlled phase 3 trial

Félix Ratjen, Christopher Hug, Gautham Marigowda et al. · The Lancet Respiratory Medicine · 2017 · 295 citations

Medicine, Pediatrics, Pharmacotherapy +12

Occurrence of Hypermutable<i>Pseudomonas aeruginosa</i>in Cystic Fibrosis Patients Is Associated with the Oxidative Stress Caused by Chronic Lung Inflammation

Oana Ciofu, Bente Juel Riis, Tacjana Pressler et al. · Antimicrobial Agents and Chemotherapy · 2005 · 251 citations

Life Sciences, Infectious Diseases, Microbiology +17